flavivirus
famili
lipidenvelop
virus
singlestrand
kb
positivesens
rna
genom
encod
ten
protein
exploit
host
machineri
complet
infecti
replic
cycl
viral
protein
shown
associ
host
cellular
function
metabol
pathway
biolog
consequ
commun
yet
clearli
understood
viru
introduc
host
infect
vector
eg
mosquito
blood
meal
flavirus
enter
cell
receptormedi
endocytosi
bind
host
endosom
acid
environ
trigger
conform
modif
envelop
e
glycoprotein
conform
chang
lead
fusion
host
viral
membran
facilit
releas
viral
genom
rna
polypeptid
co
posttransl
process
host
signalas
viru
encod
serin
proteas
translat
ten
viral
protein
three
structur
protein
envelop
e
capsid
c
premembran
prm
seven
nonstructur
protein
nonstructur
protein
involv
viral
genom
replic
bud
deploy
host
cell
machineri
follow
translat
rnadepend
rna
polymeras
rdrp
creat
negativestrand
genom
rna
becom
templat
new
posit
strand
made
rough
endoplasm
reticulum
er
viral
protein
begin
assembl
viral
rna
packag
structur
e
prm
viral
particl
transport
transgolgi
network
prm
cleav
matur
viru
releas
host
via
exocytosi
extracellular
space
figur
yellow
fever
yf
major
threat
human
health
centuri
repeat
epidem
north
america
europ
caribbean
describ
origin
viral
hemorrhag
fever
vhf
sever
yf
pansystem
viral
sepsi
viremia
fever
prostrat
hepat
renal
myocardi
injuri
hemorrhag
shock
lethal
abrupt
onset
sever
symptom
day
fever
patient
may
experi
fever
chill
malais
headach
lower
back
pain
gener
myalgia
nausea
dizzi
often
manifest
faget
sign
increas
temperatur
decreas
puls
rate
infect
human
rang
unappar
abort
infect
fatal
fulmin
diseas
high
fever
vomit
epigastr
pain
prostrat
dehydr
hepaticinduc
coagulopathi
produc
sever
hemorrhag
manifest
includ
petechia
ecchymosi
epistaxi
bleed
gum
characterist
black
vomit
hematemesi
gastrointestin
hemorrhag
infect
rate
yfv
rapidli
declin
due
success
develop
two
attenu
vaccin
current
yfv
majorli
persev
jungl
environ
sporad
human
outbreak
south
america
subsaharan
africa
present
risk
emerg
transmiss
diseas
primarili
control
wide
coverag
vulner
popul
vaccin
among
report
studi
virusinduc
ocular
complic
singl
case
studi
old
woman
travel
africa
suffer
irrevers
loss
vision
along
optic
neuriti
enceph
upon
receiv
vaccin
yellow
fever
hepat
b
causal
factor
among
multipl
vaccin
could
resolv
investig
knowledg
report
eye
infect
therefor
involv
yfv
caus
ocular
complic
still
clear
jev
causal
agent
japanes
enceph
lead
sever
neurolog
damag
known
caus
case
year
pacif
asia
symptom
depend
affect
part
nervou
system
includ
earli
symptom
nonspecif
febril
ill
diarrhea
rigor
follow
reduc
level
conscious
seizur
headach
photophobia
vomit
late
symptom
could
includ
poliomyelitislik
flaccid
paralysi
parkinsonian
syndrom
patient
exhibit
classic
descript
japanes
encephalitisdul
flat
masklik
face
wide
unblink
eye
tremor
gener
hypertonia
cogwheel
rigid
complic
locomot
frequenc
seizur
increas
sever
diseas
fatal
case
jev
patholog
chang
polymorph
diffus
involv
differ
part
nervou
system
brain
show
sever
degre
congest
vasculatur
microgli
prolifer
gliomesenchym
nodul
format
cystic
necrosi
focal
confluent
area
cerebr
edema
transcompartment
shift
also
lead
acut
coma
drastic
reduct
occurr
jev
induc
enceph
case
sinc
use
live
attenu
vaccin
lav
human
singl
case
studi
publish
old
woman
infect
jev
lead
blur
vision
retin
hemorrhag
clinic
present
ocular
fundu
vitro
studi
jev
shown
viru
infect
lead
product
macrophagederiv
neutrophil
chemotact
factor
alter
bloodretin
barrier
therebi
might
caus
observ
retin
hemorrhag
kfdv
first
report
kyasanur
forest
karnataka
india
preval
south
asia
transmit
human
anim
bite
infect
tick
haemophysali
spinigera
caus
biphas
ill
compos
acut
convalesc
phase
chief
patholog
featur
includ
hemorrhag
pneumon
hepatomegali
parenchymat
degener
nephrosi
characterist
reticuloendotheli
cell
spleen
liver
along
leucopenia
thrombocytopenia
reduc
red
blood
cell
elev
level
liver
enzym
second
nonvirem
phase
may
includ
bradycardia
meningoenceph
hemorrhag
fever
manifest
conjunctiv
inflamm
coma
neurolog
complic
mental
disturb
lightheaded
stiff
neck
abnorm
reflex
confus
tremor
kfdv
classifi
risk
group
pathogen
niaid
nation
institut
allergi
infecti
diseas
categori
c
prioriti
pathogen
due
extrem
pathogen
lack
us
fda
approv
vaccin
drug
around
case
report
annual
past
five
decad
ophthalm
present
kfdv
includ
hemorrhag
conjunctiva
vitreou
humor
retina
mild
iriti
opac
len
kerat
kfdv
report
india
studi
understand
ocular
anomali
reason
behind
complic
current
experiment
model
studi
pathogenesi
smithburn
et
al
first
isol
wnv
neuroinvas
flaviviru
west
nile
district
uganda
diseas
gain
recent
global
attent
due
report
multipl
outbreak
africa
asia
europ
unit
state
incub
period
infect
human
rang
day
along
three
differ
system
diseas
present
asymptomat
fever
meningoenceph
sever
potenti
lethal
involv
neurolog
complic
enceph
meningoenceph
acut
flaccid
syndrom
optic
neuriti
limit
past
time
wnv
increas
sever
wnv
meningoenceph
may
character
headach
photophobia
back
pain
confus
fever
ocular
involv
follow
wnv
infect
first
report
chorioretin
anterior
uveiti
retin
vascul
optic
neuriti
congenit
chorioretin
scar
around
wnv
infect
patient
neurolog
complic
suffer
multifoc
chorioretin
without
ocular
symptom
vagu
reduc
vision
multifoc
pattern
regard
earli
diagnost
marker
wnv
infect
meningoenceph
current
vaccin
antivir
wnv
infect
clinic
case
usual
recov
within
week
upon
administr
steroid
prospect
case
studi
india
reveal
posit
case
wnv
infect
report
addit
ocular
complic
apart
initi
report
fundu
examin
reveal
discret
superfici
white
retin
arter
phlebiti
retin
hemorrhag
without
macular
star
moreov
area
retin
inflamm
unclear
border
vascular
optic
disc
leakag
vessel
wall
stain
capillari
nonperfus
also
observ
one
patient
diabet
exhibit
choroid
inflamm
variou
ocular
complic
report
past
iridocycl
absenc
chorioretin
retin
retin
hemorrhag
focal
diffus
vascular
sheath
vascular
leakag
macular
edema
occlus
vascul
segment
wedgeshap
zone
atrophi
mottl
retin
pigment
epithelium
wnvassoci
optic
nerv
involv
may
occur
includ
optic
neuriti
neuroretin
optic
disc
swell
wnv
infect
rare
associ
opsoclonusmyoclonu
syndrom
om
also
known
danc
eye
syndrom
patient
rapid
involuntari
multifactori
conjug
fast
eye
movement
persist
sleep
exact
mechan
relat
optic
neuropathi
relat
wnv
still
unknown
denv
involv
caus
epidem
throughout
tropic
subtrop
sinc
onethird
world
popul
live
risk
infect
transmiss
denv
occur
human
aed
mosquito
incub
period
day
symptom
last
day
four
serotyp
denv
report
caus
dengu
fever
df
well
sever
form
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
symptom
dengu
fever
usual
includ
high
fever
sever
headach
retroorbit
pain
arthralgia
myalgia
nausea
vomit
rash
sever
form
dengu
may
lethal
individu
symptom
includ
bleed
gum
restless
fatigu
blood
vomit
thrombocytopenia
sever
form
denv
infect
mostli
occur
due
antibodydepend
enhanc
ade
preexist
antibodi
primari
infect
bind
infect
denv
particl
secondari
infect
differ
denv
serotyp
develop
sever
lifethr
infect
dengu
infect
asymptomat
recent
denv
protein
also
shown
respons
caus
vascular
leakag
vitro
vivo
model
use
marker
detect
denv
infect
dhf
patient
viral
protein
secret
cell
stay
blood
circul
patient
even
fever
viral
nucleic
acid
subsid
time
sever
dengu
hemorrhag
begin
protein
level
correl
well
degre
thrombocytopenia
tradit
ocular
patholog
dengu
fever
thought
uncommon
howev
involv
ocular
complic
recogn
increasingli
lead
perman
visual
impair
certain
case
clinic
studi
seen
diseas
correl
age
sex
ethnic
risk
factor
factor
postul
pathogenesi
dengu
ocular
diseas
includ
viral
virul
serotyp
mutat
host
suscept
geograph
factor
dengu
eye
diseas
unilater
bilater
onset
ocular
symptom
rang
day
onset
fever
ocular
symptom
note
within
one
day
peak
thrombocytopenia
one
studi
report
denv
seroposit
hospit
patient
maculopathi
main
ocular
complaint
eye
pain
retroocular
pain
blur
vision
diplopia
foreign
bodi
sensat
photopsia
floater
metamorphopsia
addit
ocular
symptom
includ
blur
vision
floater
subconjunctiv
hemorrhag
uveiti
vitriti
etc
tabl
signific
predictor
ocular
symptom
includ
leukopenia
hypoalbuminemia
could
predispos
patient
opportunist
infect
ocular
tissu
hyper
permeabl
dengu
maculopathi
well
recogn
studi
ocular
manifest
seen
serotyp
geographyrel
studi
understand
mechan
behind
dengueinduc
ocular
implic
limit
understand
diseas
patholog
one
studi
relat
maculopathi
serotyp
specif
epidem
caus
incid
case
epidem
macular
edema
macular
hemorrhag
common
find
symptomat
patient
maculopathi
cellular
molecular
mechan
understand
system
dengu
extens
studi
studi
denv
vitro
well
vivo
understand
diseas
patholog
risk
factor
eye
diseas
prevent
measur
seriou
threat
vision
dengu
retinopathi
includ
retin
vasculopathi
macular
edema
mechan
retinopathi
clearli
understood
observ
patient
implic
involv
retin
pigment
epithelium
rpe
endotheli
cell
smith
et
al
recent
shown
retin
epitheli
endotheli
cell
suscept
denv
infect
cytopath
effect
epitheli
cell
infect
decreas
epitheli
barrier
integr
endotheli
junction
intact
correl
clinic
observ
loss
rpe
denv
infect
patient
research
denv
vaccin
challeng
path
four
known
serotyp
associ
complic
partial
immun
lead
increas
diseas
sever
due
ade
live
attenu
vaccin
base
recombin
attenu
denv
serotyp
nih
recombin
yellow
fever
viru
sanofi
takeda
construct
express
prm
envelop
gene
four
serotyp
current
phase
clinic
trial
lead
candid
dengvaxia
develop
sanofi
pasteur
approv
use
individu
age
year
brazil
mexico
philippin
zika
viru
first
isol
rhesu
macaqu
zika
forest
uganda
first
human
detect
zikv
spread
throughout
part
africa
asia
zikv
epidem
yap
island
micronesia
confirm
case
last
year
rais
global
alarm
infect
peopl
countri
caus
sever
deform
newborn
neurolog
diseas
adult
apart
transmit
vector
mosquito
zikv
capabl
vertic
transmiss
human
pregnanc
deliveri
sexual
contact
contamin
blood
transfus
incub
period
zikv
rang
day
symptom
last
day
risk
transmiss
infect
escal
infect
adult
remain
asymptomat
usual
visibl
sign
infect
mild
includ
fever
rash
headach
joint
pain
conjunct
muscl
pain
may
result
guillainbarr
syndrom
congenit
contract
zikv
caus
birth
defect
newborn
microcephali
impair
brain
develop
hear
loss
seizur
impair
joint
movement
facial
deform
vision
problem
eye
adult
zikv
present
commonli
nonpurul
conjunct
howev
seriou
find
disrupt
rpe
iridocycl
report
healthi
immunocompromis
patient
first
report
congenit
zika
syndrom
cz
origin
brazil
describ
ophthalmolog
find
three
children
microcephali
caus
presum
zikv
infect
steep
increas
report
case
patholog
ocular
complic
cz
thereaft
children
present
gross
macular
pigment
mottl
foveal
reflex
loss
macular
neuroretin
atrophi
fundoscop
alter
macular
region
also
report
chorioretin
atrophi
optic
neuriti
retin
hemorrhag
retin
mottl
iri
coloboma
len
sublux
gross
macular
pigment
mottl
optic
nerv
hyperplasia
macular
chorioretin
atrophi
report
cz
case
retin
abnorm
also
report
without
microcephali
indic
capabl
zikv
caus
ocular
complic
direct
infect
first
studi
reveal
ocular
histopatholog
find
ocular
tissu
sampl
deceas
cz
fetus
fernandez
et
al
reveal
pupillari
membran
immatur
anterior
chamber
angl
loss
pigment
thin
retin
pigment
epithelium
choroid
thin
undifferenti
nuclear
layer
retina
perivascular
inflammatori
infiltr
within
choroid
viral
antigen
could
detect
iri
neural
retina
choroid
optic
nerv
current
longterm
effect
infect
unknown
report
immunocompromis
patient
indic
lesion
persist
zikv
isol
conjunctiv
swab
infect
patient
indic
abil
infect
periocular
tissu
transmit
ocular
secret
date
thirteen
open
clinic
trial
differ
phase
test
variou
concept
zikv
rang
dna
vaccin
mrna
vaccin
purifi
inactiv
viru
piv
vaccin
viralvectorbas
vaccin
sever
anim
model
use
mimic
zikv
infect
wildtyp
balbc
mice
resist
flaviviru
infect
studi
use
immunocompromis
mice
type
type
ii
interferon
knockout
mice
effici
infect
viral
replic
mimic
human
symptom
first
model
ocular
complic
zikv
infect
mice
describ
miner
et
al
subcutan
inject
viru
mice
caus
panuv
shed
viral
rna
tear
complet
absenc
live
viru
ocular
tissu
retina
seen
human
histolog
abnorm
evid
eye
congenit
infect
fetus
dam
direct
inocul
viru
organtissu
interest
anoth
approach
use
variou
group
singh
et
al
develop
new
model
ocular
zikv
infect
mimic
human
diseas
condit
inject
zikv
intravitr
eye
immunocompet
mice
knockout
mice
model
could
show
observ
patholog
find
retin
pigment
epithelium
atrophi
pigment
clumpingmottl
human
anoth
success
mous
model
show
ocular
infect
mimick
human
upon
subcutan
inject
zikv
day
old
pup
model
show
presenc
viru
ocular
tissu
till
day
pi
inflamm
subsid
dpi
therefor
model
could
use
studi
ocular
complic
zikv
well
viral
infect
understand
viral
pathogenesi
ocular
tissu
mous
model
zikv
shown
infect
multipl
ocular
cell
type
zikv
inocul
mice
develop
conjunct
panuv
infect
cornea
iri
optic
nerv
retina
well
detect
viral
rna
tear
studi
exhibit
abil
zikv
infect
previous
unexplor
cell
type
eye
need
research
investig
relationship
paramount
import
studi
indic
spread
viru
via
two
mode
hematogen
axon
also
support
fernandez
et
al
viru
could
reach
fetal
circul
placenta
infect
rpe
retin
endotheli
cell
retina
possibl
pathway
would
axon
transport
eye
along
optic
nerv
lead
ganglion
cell
layer
gcl
loss
foveal
maldevelop
central
chorioretin
abnorm
zikv
flavivirus
enter
eye
vivo
remain
determin
sinc
wildtyp
mice
suscept
zikv
vitro
studi
use
primari
human
cell
establish
cell
line
exampl
singh
et
al
recent
report
retin
cell
type
line
brb
suscept
zikv
infect
caus
cell
death
activ
caspas
zhao
et
al
aleman
et
al
independ
shown
muller
glia
cell
primari
target
zikv
infect
lead
decreas
neurotrop
function
increas
proinflammatori
cytokin
post
infect
help
murin
model
zikv
infect
rpe
shown
disrupt
cell
cell
adhes
barrier
properti
similarli
zikv
found
infect
human
fetal
retin
pigment
epitheli
cell
frpe
ipscderiv
retin
stem
cell
irsc
retin
cup
rc
organoid
underli
mechan
detail
sketch
breach
brb
caus
ocular
patholog
address
till
current
field
zikv
research
undecid
role
protein
tyrosin
kinas
tam
axl
zikv
entri
cell
tam
receptor
shown
upregul
retin
epitheli
endotheli
primari
cell
zikv
infect
role
still
debat
rpe
cell
multifunct
help
transport
nutrient
wast
retina
across
choroid
impart
adhes
properti
retina
bok
form
first
line
defens
pathogen
retina
role
innat
well
adapt
immun
cell
identifi
ideal
target
infecti
agent
cytomegaloviru
toxoplasma
gondii
coronaviru
zika
viru
produc
varieti
cytokin
chemokin
growth
factor
act
antigen
present
cell
apc
retina
upon
pathogen
assault
immun
cell
resid
within
ocular
tissu
upon
infect
peripher
immun
cell
gain
access
eye
lead
local
inflamm
despit
upsurg
interest
rpe
cell
critic
role
retin
health
diseas
exact
mechan
rpe
cell
particip
regul
bloodretin
barrier
remain
larg
unknown
retina
also
contain
special
myeloid
cell
microglia
similar
brain
microglia
central
peripher
rim
retina
contain
small
popul
dcir
mhc
class
iihi
dc
corneal
peripheri
addit
neuron
retina
contain
glial
cell
microglia
muller
glia
astrocyt
provid
structur
support
play
import
role
evok
retin
innat
respons
injuri
infecti
stimuli
retin
residenti
glial
cell
regul
innat
immun
activ
area
investig
laboratori
similarli
cell
line
brb
also
contribut
retin
immun
respons
microbi
infect
zikv
infect
rpe
muller
glia
retin
endotheli
cell
lead
increas
marker
innat
immun
respons
along
interferon
interferon
stimul
gene
respons
time
depend
manner
caus
chorioretin
atrophi
rpe
mottl
cell
death
vitro
well
vivo
model
zikv
induc
express
axl
retin
cell
type
except
photoreceptor
cell
tam
receptor
seem
domin
receptor
use
infect
retin
cell
type
zikv
infect
lead
increas
innat
immun
respons
increas
express
along
increas
express
viral
recognit
rigi
increas
ocular
patholog
due
inflamm
caus
signific
product
rant
increas
express
inflammatori
gene
tnfa
lead
ocular
inflamm
infect
also
lead
elev
level
granzym
b
perforin
ifn
ifn
stimul
recent
manangeeswaran
et
al
report
subcutan
infect
also
lead
symptomat
posterior
uveiti
could
replic
infect
patient
employ
wildtyp
mous
model
model
demonstr
preferenti
infect
cornea
retina
caus
chorioretin
lesion
upon
zikv
infect
infect
elicit
inflammatori
respons
character
increas
local
chemokin
express
infiltr
neutrophil
apc
natur
killer
cell
cell
later
stage
infect
subsid
dpi
cytotox
cell
remain
eye
along
express
sever
chemokin
studi
also
show
cornea
retina
higher
level
chemokin
associ
infiltr
cell
along
biomark
apc
tcell
infiltr
gitr
fasl
caus
increas
cytotox
infect
tissu
new
model
studi
could
prove
help
dissect
mechan
breach
brb
zikv
infect
variou
alter
occur
ocular
tissu
mimic
vector
bite
follow
infect
inflamm
eye
similar
symptom
human
zikv
infect
act
key
player
confin
viral
replic
retinaey
mostli
posit
loop
regul
interferon
signal
backfir
antivir
immun
infect
host
lead
huge
amount
tissu
inflamm
tissu
damag
lead
vision
loss
complic
also
evid
fetu
develop
anoth
parallel
studi
primari
muller
glia
cell
demonstr
high
suscept
zikv
infect
induc
robust
inflammatori
respons
activ
sever
intracellular
pathway
includ
erk
nfkb
er
stress
therebi
influenc
differenti
express
growth
inflammatori
factor
shown
strongli
control
express
inflammatori
pathway
proven
highli
potent
mani
viral
infect
includ
zikv
virus
nonliv
entiti
possess
individu
metabol
alter
host
cellular
metabol
pathway
optim
replic
flavivirus
known
subvert
cholesterol
homeostasi
use
multipl
mechan
transform
lipid
droplet
replic
complex
host
membran
identifi
uniqu
molecular
signatur
zikv
infect
rpe
singh
et
al
perform
metaanalysi
zikv
infect
rpe
cell
relat
flavivirus
denv
jev
wnv
led
identif
gene
signatur
refer
core
signatur
gene
dysregul
upon
zikv
infect
flavivirus
test
valid
identifi
gene
signatur
reveal
zikv
modul
upregul
express
rel
higher
level
denv
interestingli
pathway
analysi
reveal
zikv
alter
cellular
metabol
involv
adaptor
activ
lipid
metabol
ceramid
metabol
gene
may
help
evad
immun
system
attenu
inflammatori
respons
infiltr
innat
immun
cell
site
infect
reduct
enzym
activ
would
lead
increas
endogen
level
ghb
gammahydroxybutyr
acid
gaba
gammaaminobutyr
acid
level
lead
neurolog
manifest
zikv
infect
microcephali
guillainbarr
syndrom
adult
zikv
capsid
protein
recent
shown
hijack
host
lipid
metabol
effici
viral
replic
interact
nucleolar
protein
facilit
replic
among
highli
alter
gene
membran
transport
involv
cholesterol
efflux
innat
immun
respons
among
top
candid
moreov
inhibit
result
reduc
zikv
replic
rpe
cell
host
cell
lipid
cholesterol
play
essenti
role
variou
stage
viral
replic
includ
entri
uncoat
genom
replic
assembl
releas
import
understand
molecul
exploit
viru
exploit
drug
target
therapeut
purpos
recent
studi
global
interactom
reveal
hijack
lipid
metabol
machineri
zikv
capsid
protein
interact
zikv
protein
peroxisomeassoci
polypeptid
govern
lipid
traffick
innat
immun
regul
host
cell
effici
replic
viru
lipid
metabol
machineri
central
control
ampk
amp
activ
protein
kinas
one
master
regul
variou
cellular
metabol
pathway
ampk
promin
role
bacteri
endophthalm
activ
pharmacolog
drug
lead
signific
decreas
bacteri
load
infect
eye
ampk
known
alter
flaviviru
infect
pro
well
antivir
activ
upon
activ
differ
virus
role
zikv
infect
ocular
patholog
studi
till
studi
ongo
laboratori
understand
role
viral
replic
breach
brb
alter
intercellular
junction
machineri
ocular
complic
caus
flavivirus
virus
longterm
econom
psycholog
health
implic
therefor
deeper
understand
interact
viral
pathogenesi
eye
help
discoveri
repurpos
therapeut
drug
protect
viralborn
ocular
abnorm
known
effect
antivir
treatment
vaccin
emerg
flavivirus
infect
patient
provid
palli
care
upon
diagnosi
incid
flaviviru
infect
reduc
supervis
vector
control
prevent
bite
vector
therapeut
approach
decreas
viral
load
combin
regul
immun
cascad
respons
eye
could
save
patient
detriment
ocular
consequ
futur
investig
immunedefici
immunecompet
mous
model
zikv
infect
may
help
identifi
key
hostpathogen
factor
devis
novel
therapi
restrain
system
local
inflammatori
respons
associ
zikv
infect
eye
sever
ocular
complic
due
viral
infect
present
addit
stress
challeng
commun
alreadi
devast
loss
life
commun
infrastructur
flaviviru
infect
seen
increasingli
endem
nonendem
region
result
increas
intern
travel
therefor
ophthalmologist
requisit
knowledg
diagnos
manag
patient
keep
track
patient
histori
exposur
viral
infect
earli
diagnosi
viralrel
ocular
complic
sinc
transmiss
system
flavivirus
overlap
high
probabl
mani
patient
zikv
infect
also
previou
exposur
least
one
denv
serotyp
likewis
mani
patient
expos
zikv
highli
like
expos
least
one
denv
serotyp
futur
report
increas
sever
zikv
infect
individu
infect
denv
recent
past
via
mechan
similar
ade
therefor
preexist
immun
one
flaviviru
affect
clinic
outcom
diagnosi
diseas
produc
infect
heterolog
flaviviru
secret
denv
protein
marker
denv
infect
patient
shown
causal
factor
sever
dengu
hemorrhag
cell
cultur
vivo
studi
zika
viru
close
relat
member
famili
may
also
share
similar
antigen
role
secret
protein
may
potenti
candid
caus
retin
hemorrhag
ocular
complic
possibl
mediat
breach
bloodretin
barrier
ocular
complic
usual
outcom
robust
immun
respons
host
follow
infect
denv
infect
hemorrhag
caus
tissu
mostli
due
cytokin
storm
invad
immun
cell
tissu
therebi
increas
sever
diseas
invad
immun
cell
eye
could
also
exacerb
sever
complic
damag
retina
blood
vessel
due
respons
control
infect
inflamm
infiltr
cell
may
play
key
role
clear
viru
may
also
contribut
develop
lesion
understand
role
immun
respons
gener
persist
retin
lesion
may
enlighten
help
use
immun
suppressor
corticoid
later
stage
diseas
flavivirus
employ
host
lipid
metabol
machineri
replic
make
potent
target
therapeut
purpos
flavivirus
shown
impair
intercellular
junction
integr
via
differ
cellular
intermedi
caus
breach
barrier
via
tight
junction
adheren
junction
protein
alter
degrad
littl
research
conduct
understand
pathogenesi
zikv
breach
bloodretin
barrier
caus
ocular
complic
recent
studi
use
transcriptom
approach
retin
epitheli
cell
major
compon
outer
bloodretin
barrier
indic
involv
cholesterol
metabol
viral
replic
target
host
cellular
metabol
could
allevi
ocular
complic
due
zikv
infect
therefor
deeper
understand
ocular
pathogenesi
viral
diseas
interact
variou
cell
type
involv
bloodretin
barrier
etch
path
toward
invent
repurpos
therapeut
drug
prevent
vision
loss
infect
patient
ocular
complic
viral
infect
underreport
mostli
due
late
ignor
investig
ophthalmologist
ophthalmologist
crucial
role
help
decreas
ocular
complic
awar
chang
symptom
flaviviru
infect
complet
patient
histori
previou
exposur
viral
infect
rule
secondari
infect
complic
